Aquestive Therapeutics, Inc.

By person

23 insiders · 72 transactions

4.7×

Daniel Barber holds only 4.7 times base salary in stock. $3.14M of shares against $659.89K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Barber last reported holding, valued at $4.82, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

BRATTON DOUGLAS K

10% owner

$2.48M (1)

—

+$2.48M

2,161,004

1.72%

$10.41M

−43.0%

Barber Daniel

President and CEO

$104.05K (3)

$1.77M (9) scheduled

−$1.67M

652,317

0.5197%

$3.14M

+714.7%

Schobel Alexander Mark

Chief Innovation/Tech Officer

$79.45K (4)

$1.62M (9)

−$1.54M

984,476

0.7844%

$4.74M

−2.4%

Jung Cassie

Chief Operating Officer

—

$975.90K (4) scheduled

−$975.90K

208,833

0.1664%

$1.01M

+502.6%

Boyd Peter E.

Chief People Officer

$13.53K (5)

$336.91K (4) scheduled

−$323.38K

284,024

0.2263%

$1.37M

+472.0%

TOTH A ERNEST JR

Chief Financial Officer

—

$243.09K (1)

−$243.09K

283,460

0.2258%

$1.37M

—

Kraus Carl N

Chief Medical Officer

—

$141.90K (1) scheduled

−$141.90K

282,475

0.2251%

$1.36M

—

Kendall Keith J

CEO and President

$121.18K (9)

$255.31K (1)

−$134.13K

639,149

0.5092%

$3.08M

+4.4%

Krop Julie

Director

—

$125.39K (1) scheduled

−$125.39K

0.0000%

$0.00

—

Maxwell John T.

SVP-Chief Financial Officer

$142.35K (2)

$24.00K (1)

+$118.35K

150,614

0.1200%

$725.88K

+8.7%

Korczynski Sherry

Chief Commercial Officer

—

$111.36K (2)

−$111.36K

235,689

0.1878%

$1.14M

+371.4%

Cioffi Melina

SVP, Regulatory Affairs

—

$105.62K (1)

−$105.62K

273,200

0.2177%

$1.32M

+49.9%

Scibetta James S

Director

$86.98K (3)

—

+$86.98K

31,635

0.0252%

$152.46K

+265.1%

BRAENDER LORI J

Corporate Secretary

$86.15K (4)

$167.35K (1)

−$81.19K

231,042

0.1841%

$1.11M

—

Marshall Ken W.

SVP, Chief Commercial Officer

$14.67K (1)

—

+$14.67K

151,445

0.1207%

$729.89K

—

Wood Theresa

SVP-HR and Org. Development

$9.16K (2)

—

+$9.16K

80,765

0.0643%

$389.25K

+1.9%

Wargacki Stephen

Chief Science Officer

—

343,552

0.2737%

$1.66M

+1,722%

Zalewski Thomas A.

Chief Legal Officer

—

100,000

0.0797%

$481.95K

—

Davis Matthew W.

Chief Development Officer

—

100,000

0.0797%

$481.95K

—

Cochran John

Director

—

99,486

0.0793%

$479.47K

+32.5%

BROWN GREGORY B

Director

—

75,085

0.0598%

$361.87K

0.0%

Greenhawt Matthew J.

Chief Medical Officer

—

75,000

0.0598%

$361.46K

—

COSTA SANTO J

Director

—

17,327

0.0138%

$83.51K

0.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Jung Cassie

10 Mar 2026

Chief Operating Officer

Sell

45,791

$4.17

$191.09K

Korczynski Sherry

10 Mar 2026

Chief Commercial Officer

Sell

15,741

$4.17

$65.69K

TOTH A ERNEST JR

10 Mar 2026

Chief Financial Officer

Sell

58,254

$4.17

$243.09K

Cioffi Melina

10 Mar 2026

SVP, Regulatory Affairs

Sell

25,311

$4.17

$105.62K

BRAENDER LORI J

10 Mar 2026

Chief Legal Officer

Sell

40,102

$4.17

$167.35K

Barber Daniel

10 Mar 2026

President and CEO

Sell

180,677

$4.17

$753.97K

Boyd Peter E.

10 Mar 2026

Chief People Officer

Sell

29,814

$4.17

$124.41K

Jung Cassie

26 Nov 2024

Chief Operating Officer

Sell indirect

$4.87

$214.06

Schobel Alexander Mark

10 Feb 2021

Chief Innovation/Tech Officer

Sell

23,460

$6.75

$158.36K

Schobel Alexander Mark

9 Feb 2021

Chief Innovation/Tech Officer

Sell

11,540

$6.75

$77.90K

Schobel Alexander Mark

8 Feb 2021

Chief Innovation/Tech Officer

Sell

40,792

$6.50

$265.15K

Maxwell John T.

18 Aug 2020

SVP-Chief Financial Officer

Sell

3,000

$8.00

$24.00K

Kendall Keith J

4 Jun 2020

CEO and President

Sell

50,000

$5.11

$255.31K

Schobel Alexander Mark

8 May 2020

Chief Innovation/Tech Officer

Sell

40,000

$5.00

$200.00K

Schobel Alexander Mark

29 Apr 2020

Chief Innovation/Tech Officer

Sell

40,000

$4.50

$180.00K

Schobel Alexander Mark

27 Apr 2020

Chief Innovation/Tech Officer

Sell

40,000

$4.00

$160.00K

Schobel Alexander Mark

14 Apr 2020

Chief Innovation/Tech Officer

Sell

40,000

$3.70

$148.00K

Show all 72 transactions →

Aquestive Therapeutics, Inc.

By person

Individual transactions

What was left out